Long-acting HIV prevention injection trials resumed
Friday, September 28, 2018
The HIV Prevention Trials Network (HPTN) 084, is a study being done to evaluate the safety and efficacy of the injectable agent, cabotegravir (CAB LA) compared to daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women.
When addressing different stakeholder at the HPTN meeting at the institution at Princess Marina Referral Hospital this week, Shava said they had to put the study on hold last year after there were misunderstanding over the DTG drug used to treat HIV infection.
The recent disclosure by the IEC that 2,513 registrations have been turned down due to various irregularities should prompt all Batswana to meticulously review the voters' rolls and address concerns about rejected registrations.The disparities flagged by the IEC are troubling and emphasise the significance of rigorous voter registration processes.Out of the rejected registrations, 29 individuals were disqualified due to non-existent Omang...